Policy / Regulatory

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

The National Medical Products Administration (NMPA) has released the 110th batch of the Catalog of Reference Listed Drugs (RLD) for Chemical Generic Drugs, adding 28 new drug specifications and providing…

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
SSY Group Limited Projected to Win 12 Products in China’s Eleventh Volume‑Based Procurement Round
HKG: 2005SSY Group

SSY Group Limited Projected to Win 12 Products in China’s Eleventh VBP Round

NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov 5
NMPA

NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov 5

Novartis Asciminib Enters China’s SPARK Program for Pediatric Chronic Myeloid Leukemia
CancerNYSE: NVS

Novartis Asciminib Enters China’s SPARK Program for Pediatric Chronic Myeloid Leukemia

NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs
GQCE testing

NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs

Show More